Veranova · 6 days ago
Analytical Scientist - Anti Body Drug Conjugates
Veranova is a global leader in the development and manufacturing of complex active pharmaceutical ingredients for pharma and biotech customers. They are seeking a highly motivated and skilled Analytical Scientist to join their Analytical team, responsible for LCMS characterization of bioconjugates and ensuring compliance with regulatory guidelines.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Exercise technical judgment in the planning, implementation, and analysis of experiments related to method development, validation, reference standard creation and qualification, forced degradation, product characterization, and compatibility studies in accordance with pertinent ICH regulatory guidelines
Develop and optimize LCMS methods for qualitative and quantitative analysis of ADCs. Develop and validate quantitative LCMS methods such as: Drug-to-Antibody Ratio (DAR) determination. Payload quantification (free and conjugated forms). Linker stability and degradation profiling. Site-specific conjugation analysis
Perform intact mass analysis, peptide mapping, drug-to-antibody ratio (DAR) determination, and payload identification
Characterize ADCs for critical quality attributes including conjugation sites, linker stability, and degradation products
Author test methods, protocols, reports, and regulatory documents as needed
Provide support for development and cGMP manufacturing campaigns, ensuring compliance with regulatory requirements and documentation standards - including both in-process and release samples
Adhere to safety and quality standards
Communicate technical findings and results to both internal and external stakeholders, including clients and regulatory bodies
Collaborate with chemistry development scientists, quality control and regulatory affairs teams to ensure successful project delivery
Mentor and develop scientific staff. Ensure continued technical and professional growth of department members, encourage efforts towards excellence and knowledge sharing
Possess strong communication (oral, written), organizational, and leadership skills
Maintain and troubleshoot LCMS instrumentation (e.g., Orbitrap, Q-TOF, Triple Quad)
Qualification
Required
Ph.D., M.S., or B.S. in Analytical Chemistry, Biochemistry, Chemistry, Chemical/Biomedical Engineering, or other related scientific discipline
Relevant experience in analytical method development, validation and characterization of bioconjugates. (PhD with 4+ years, MS with 6+ years, BS with 8 + years of experience
4+ years of hands-on experience in LCMS analysis of biologics, preferably ADCs
Strong knowledge of protein chemistry, conjugation technologies, and biotherapeutic development
Proficiency in any of the software tools for MS data analysis (e.g., Xcalibur, MassHunter, Skyline, Biopharma Finder)
Well organized with good problem-solving skills, a high level of attention to detail and have a passion for delivering high quality data in a fast-paced environment
Preferred
Experience with regulatory submissions and GMP/GLP environments
Experience with various techniques used in the characterization of ADC's such as capillary electrophoresis (CE-SDS) for ADC purity and size analysis, hydrophobic interaction chromatography (HIC) for DAR profiling, size-exclusion chromatography (SEC) for aggregation and stability studies, UV-Vis spectroscopy and fluorescence-based assays for payload quantification, and immunoassays (ELISA, ECL) for antibody detection
Benefits
Comprehensive health & wellness benefits.
Access to mental health resources and wellness programs.
Generous PTO and holiday pay policies.
Eligibility for performance-based bonuses.
Attractive 401(k) Plan with company match.
Opportunities for continuous learning through LinkedIn Learning, workshops, conferences, and mentorship.
Tuition Assistance for Undergraduate and Graduate degree programs.
Company
Veranova
Veranova develops and manufactures active pharmaceutical ingredients(APIs).
Funding
Current Stage
Late StageTotal Funding
unknown2022-06-01Acquired
Leadership Team
Recent News
2025-08-01
Company data provided by crunchbase